SAN FRANCISCO, June 06, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular’s PIVO™ needle-free device for blood draws was named Best Overall Medical Device Solution by the 2018 MedTech Breakthrough Awards. Selected from among more than 3,000 nominations, PIVO was honored for its work in advancing a new, more humane standard of care for hospital patients.
More than one billion inpatient blood draws occur around the world every year, informing nearly 70% of all medical decisions. However, the rising incidence of aging, obesity and chronic illness is making venous access more difficult and less efficient. These patients, known as Difficult Venous Access (DVA), represent more than 30% of all hospitalized patients worldwide.
Velano’s pioneering technologies are ushering in a new standard of care for vascular access in hospitals. The company’s FDA-cleared PIVO device enables high quality blood draws from indwelling peripheral IV lines, and is currently in use at a number of health systems around the country.
“Modern hospital medicine hinges on reliable venous access and successful blood collection, but this procedure has historically relied on outdated practices that are painful, inefficient, and put both patients and practitioners at risk,” said Velano Vascular Chief Executive Eric M. Stone. “As a company founded by a patient and a practitioner, we are committed to building a family of technology solutions that hospitals around the world can use to improve vascular access, reduce infection, and create a true and more humane standard of care for blood collection.”
The MedTech Breakthrough Awards recognize the top companies, people, platforms and products in the health, fitness and medical technology industries today. Fellow 2018 Award winners include GE Healthcare, WebMD, Philips Healthcare, 23andMe, Samsung, Humana, Stryker, and Apple.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
Press Contact:
Michael Azzano
Cosmo PR
michael@cosmo-pr.com
415-596-1978
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c31a9999-b33a-4fe8-a341-d2d931787bab.